171 filings
Page 3 of 9
6-K
1mrcpjnf50go h8ei
18 Apr 23
GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
4:10pm
F-3
ie40zco7gpjrre1hyg
18 Apr 23
Shelf registration (foreign)
2:33pm
S-8
pe30ua0j8
18 Apr 23
Registration of securities for employees
2:13pm
6-K
si5tf6x
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
6-K
cmrh6qubwwib8tzxxo
28 Feb 23
Current report (foreign)
4:10pm
6-K
xpzaek3kns
30 Jan 23
Current report (foreign)
4:10pm
6-K
4rialshr
24 Jan 23
GENFIT Announces 2023 Financial Calendar
4:10pm
6-K
hobkzo3i3 r3w6rw
5 Jan 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
7uxhz2j
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
po6r ubc2n0n
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
tkd 7ylutw6rf0zhhu
25 Oct 22
Current report (foreign)
4:10pm
6-K
hcca2 pouy
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
qbiz9g
28 Sep 22
GENFITÂ Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
ymyd0qm
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
xmahesim2p485a0q
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
45lct 30r9g7e5wg2
8 Jul 22
Current report (foreign)
4:15pm
6-K
bh8grxk0sadm26 x5
25 May 22
Current report (foreign)
4:10pm
6-K
b34u hyof0acb
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
a2shx5o80ss92qk
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm